Home
  >  
Section 48
  >  
Chapter 47,210

Regional drug-induced sympathicolysis in patients with arterial occlusive disease

Heimig, T.; Scheffler, A.; Rieger, H.; Acevedo, A.

Wiener Medizinische Wochenschrift 143(7-8): 184-185

1993

ISSN/ISBN: 0043-5341
PMID: 8379171
Accession: 047209008
Download citation:  
Text
  |  
BibTeX
  |  
RIS
Regional drug-induced sympathectomy is a modification of Bier's block technique. By applying this method skin perfusion in patients with occlusions of lower leg arteries or functional disturbance of peripheral circulation can be improved. Under optimal technical conditions effects of regional and surgical sympathectomy are comparable. Fluorescence angiography can be applied to assess the effectiveness of drug-induced as well as surgical sympathectomy.

PDF emailed within 1 workday: $29.90




Related References

Mahli, A; Coskun, D; Unal, B; Gulay, C; Erer, D; Iriz, E 2004: Percutaneous lumbar sympathicolysis in peripheral arterial occlusive disease: Our own experiences and literature review Regional Anesthesia and Pain Medicine 29: 97-97
Finkenzeller, T.; Techert, J.; Lenhart, M.; Link, J.; Feuerbach, S. 2001: CT-guided thoracal sympathicolysis for the treatment of peripheral arterial occlusive disease and chronic thoracal pain syndromes in 6 patients Rofo: Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin 173(10): 920-923
Duda, S.H.; Huppert, P.E.; Heinzelmann, B.; Schareck, W.; Seboldt, H.; Claussen, C.D. 1994: CT-guided percutaneous lumbar sympathicolysis in peripheral arterial occlusive diseases Rofo: Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin 160(2): 132-136
Moerl, H.; Diehm, C.; Mechtersheimer, U. 1981: Drug induced hypertension in treatment of arterial occlusive disease Vasa 10(2): 151-155
Finkenzeller, T.; Techert, J.; Lenhart, M.; Link, J.; Feuerbach, S. 2001: CT-gesteuerte thorakale Sympathikolyse zur Behandlung der peripheren arteriellen Verschlusskrankheit und thorakaler Schmerzen in 6 Fällen - CT-guided thoracal sympathicolysis for the treatment of peripheral arterial occlusive disease and chronic thoracal pain syndromes in 6 patients Rofo. Fortschritte auf dem Gebiet der Rontgenstrahlen und der Bildgebenden Verfahren 173(10): 920-923
Hess, H.; Mietaschk, A.; Deichsel, G. 1985: Drug-Induced Inhibition of Platelet Function Delays Progression of Peripheral Occlusive Arterial Disease The Lancet 325(8426): 415-419
Creutzig, A.; Alexander, K. 1985: Drug-induced alterations in muscle tissue oxygen pressure in patients with arterial occlusive disease International Journal of Microcirculation Clinical and Experimental 4(2): 173-181
2004: Patients with arterial occlusive disease die of myocardial infarct or stroke. The dangerous sisters: arterial occlusive disease and coronary heart disease MMW Fortschritte der Medizin 146 Suppl. 1: 6-7
Bullinger, M.; Cachovan, M.; Creutzig, A.; Diehm, C.; Gruss, J.; Heidrich, H.; Kirchberger, I.; Loeprecht, H.; Rogatti, W. 1996: Development of an illness-specific instrument for assessment of quality of life in patients with arterial occlusive disease (Peripheral Arterial Occlusive Disease 86 Questionnaire) Vasa. Zeitschrift für Gefasskrankheiten 25(1): 32-40
Hess, H.; Mietaschk, A.; Deichsel, G. 1985: Drug-induced inhibition of platelet function delays progression of peripheral occlusive arterial disease. a prospective double-blind arteriographically controlled trial Lancet 1(8426): 415-419
Hess, H.; Mietaschk, A.; Deichsel, G. 1985: Drug-induced inhibition of platelet function delays progression of peripheral occlusive arterial disease: a prospective double-blind arteriographically controlled trial Lancet (British Edition) (8426): 415-419
Esfahani, F.; Rooholamini, S.A.; Azadeh, B.; Daneshbod, K. 1989: Arterial fibrodysplasia: a regional cause of peripheral occlusive vascular disease Angiology 40(2): 108-113
Battke, K.; Buchwalsky, R.; Barmeyer, J.; Hoffmann, G.; Reindell, H. 1978: Therapy of arterial occlusive diseases. the effect of bencyclan in trained patients with peripheral arterial occlusive disease (Double-blind study) Fortschritte der Medizin 96(26-27): 1381-1386
Dudman, N.P.B.; Xuewei, G.U.O.; Gordon, R.B.; Dawson, P.A.; Wilcken, D.E.L. 1996: Human homocysteine catabolism: Three major pathways and their relevance to development of arterial occlusive disease : Homocyst(e)ine, vitamins and arterial occlusive diseases J. Nutr 126(4): 1295S-1300S
Hooi, J.D.; Stoffers, H.E.; Kester, A.D.; Rinkens, P.E.; Kaiser, V.; van Ree, J.W.; Knottnerus, J.A. 1998: Risk factors and cardiovascular diseases associated with asymptomatic peripheral arterial occlusive disease. The Limburg PAOD Study. Peripheral Arterial Occlusive Disease Scandinavian Journal of Primary Health Care 16(3): 177-182
Mörl, H. 1978: Arterial occlusive disease. Metabolism and hemodynamics of the most severe stages of arterial occlusive disease Zfa. Zeitschrift für Allgemeinmedizin 54(1): 15-20
Diehm, C.; Heidrich, H.; Spengel, F.; Schulte, K.L.; Theiss, W. 2000: Drug therapy of arterial occlusive disease Der Internist 41(12): 1416-1422
Mahler, F. 1981: Drug therapy of peripheral arterial occlusive disease Schweizerische Medizinische Wochenschrift 111(18): 637-640
Bollinger, A. 1988: Drug therapy in peripheral arterial occlusive disease Schweizerische Medizinische Wochenschrift 118(36): 1283-1289
Mörl, H.; Diehm, C.; Mechtersheimer, U. 1981: Drug-induced hypertension in the treatment of arterial occlusive diseases Vasa. Zeitschrift für Gefasskrankheiten 10(2): 151-155